Subarachnoid hemorrhage associated with tadalafil

Sheikh-Taha, Marwan; Alaywa, Rayan Abu
July 2011
American Journal of Health-System Pharmacy;7/1/2011, Vol. 68 Issue 13, p1195
Academic Journal
The article highlights a link between the use a type-5 (PDE5) inhibitor used for treating erectile dysfunction, tadalafil and the subarachnoid hemorrhage (SAH). It discusses a case of a 45-year-old man, who had been taking tadalafil without consultation, and was diagnosed with SAH. Details related to cases of SAH and intracerebral hemorrhage (ICH) after the ingestion of tadalafil, sildenafil and vardenafil is provided. The article suggests such medication should be prescribed cautiously.


Related Articles

  • Relation of C-reactive protein and other cardiovascular risk factors to penile vascular disease in men with erectile dysfunction. Bank, A.J.; Billups, K.L.; Kaiser, D.R.; Kelly, A.S.; Wetterling, R.A.; Tsai, M.Y.; Hanson, N. // International Journal of Impotence Research;Aug2003, Vol. 15 Issue 4, p231 

    Erectile dysfunction (ED) may be an early sign or symptom of cardiovascular disease (CVD). We examined the relation of traditional and emerging risk factors for CVD to the severity of penile vascular disease in men with ED and without clinical coronary artery disease (CAD). In total, 137 men...

  • Erectile dysfunction linked to CVD risk.  // Independent Nurse;4/30/2010, p1 

    The article discusses a study conducted by Dr Giovanni Corona and colleagues that demonstrate that cardiovascular patients with low testosterone levels exhibit higher mortality rates than the ones with high testosterone levels.

  • ED linked with 43% higher risk of CVD-related death. Bankhead, Charles // Urology Times;Nov2009, Vol. 37 Issue 12, p18 

    The article reports on the relevance of erectile dysfunction (ED) and cardiovascular disease (CVD) based on the study conducted by Dr. Andre B. Araujo in Watertown, Massachusetts. According to data in the study, ED may represent an early warning sign for CVD. It states that the rate of CVD...

  • Recommendations for Using Sildenafil in Men at Risk of CV Effects.  // Modern Medicine;Oct98, Vol. 66 Issue 10, p38 

    Discusses the abstract of a study on the use of anti-impotency drug sildenafil citrate (Viagra) in men at risk from cardiovascular effects, presented in the summary statement of the American College of Cardiology and the American Heart Association.

  • Erectile Dysfunction Signals Increased Risk of Dying Over 2.8 Year Period. Dye, D. // Life Extension;May2013, Vol. 19 Issue 5, p3 

    The article discusses a report published in "PLOS Medicine" which linked the incidence of erectile dysfunction (ED) symptoms in men to an increased risk of heart disease and overall mortality.

  • ED, frequency of sexual activity linked to CVD. Krader, Cheryl Guttman // Urology Times;Apr2010, Vol. 38 Issue 4, p25 

    The article presents a study which investigates the relation of the frequency of sexual activity to cardiovascular disease (CVD) conducted by researchers from the New England Research Institute, Watertown, Massachusetts. A cohort study of 1,709 men with ages from 40 to 70 years old was conducted...

  • Physical activity and erectile dysfunction: meta-analysis of population-based studies. Cheng, J. Y. W.; Ng, E. M. L.; Ko, J. S. N.; Chen, R. Y. L. // International Journal of Impotence Research;May/Jun2007, Vol. 19 Issue 3, p245 

    We searched for population-based cross-sectional studies, cohort studies and randomized controlled trials (RCTs) on erectile dysfunction (ED) through Medline, PubMed, PsychInfo and scanned though reference lists. Studies that did not include adjusted odds ratios (OR) of physical activity were...

  • Udenafil.  // Reactions Weekly;1/11/2014, Issue 1483, p94 

    The article presents a case study of a 63-year old man who developed a nonaneurysmal subarachnoid haemorrhage after receiving udenafil.

  • Nitric Oxide Synthase-Dependent Vasodilation of Human Subcutaneous Arterioles Correlates With Noninvasive Measurements of Endothelial Function. Dharmashankar, Kodlipet; Welsh, Aimee; Wang, Jingli; Kizhakekuttu, Tinoy J.; Ying, Rong; Gutterman, David D.; Widlansky, Michael E. // American Journal of Hypertension;May2012, Vol. 25 Issue 5, p528 

    BackgroundNoninvasive measurements of endothelial function predict future adverse cardiovascular events, but offer limited opportunities for mechanistic insights into phenotypic observations. Subcutaneous adipose arterioles, accessible through minimally invasive methods, provide an opportunity...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics